Why the study?
Current commercial transcatheter heart valves do not fully meet clinical needs, necessitating new biological materials.
Does yak pericardium demonstrate superior biomaterial properties compared to bovine and porcine pericardium for use in transcatheter heart valves?
Does yak pericardium demonstrate superior biomaterial properties compared to bovine and porcine pericardium for use in transcatheter heart valves?
Yak pericardium shows promise as a novel biomaterial for transcatheter heart valves due to its favorable mechanical properties, low immunogenicity, and anti-calcification effects.
No takes yet. Share an insight, caveat, or question.
Yak pericardium merits evaluation for transcatheter valves; hypothesis-generating in animals and should not change practice.
Song et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: